Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: January 27, 2009
Reporting Period: Fourth quarter and full year ended December 31, 2008.
This filing serves as a notification that the Company issued a press release announcing its financial results for the specified period. The detailed financial data is contained in the press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2), which are incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced Exhibit 99.1 (Press Release) and Exhibit 99.2 (Supplemental Information), which are not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the fourth quarter and twelve months of 2008 were announced.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information is expected to be found in the incorporated press release and supplemental exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and earnings per share figures for Q4 and full-year 2008.
- Examine Exhibit 99.2 for supplemental data regarding product sales, R&D expenses, and cash flow details not included in the main press release.
- Verify any guidance or outlook statements provided by management in the referenced press release.
- Check for any restatements or unusual items disclosed in the full text of the press release.